×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| SMS Lifesciences India Ltd | 846.58 | 48.53 | 846.01 | 18.08 | 353.0 | 16.8 |
| AMBALAL SARABHAI ENTERPRISES L | 515.80 | 22.32 | 459.71 | 0.29 | 329 | 23.2 |
| BROOKS LABORATORIES LTD. | 205.43 | -21.32 | 205.15 | -0.82 | 325 | 184.0 |
SMS Lifesciences India Ltd, with Security Code 540679, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 80.4 | 78.4 | 90.7 | 65.5 | 74.5 | 67.8 | 71.2 | 86.3 | 86.5 | 78.4 |
| Expenses | 71.6 | 72.0 | 82.5 | 63.0 | 69.4 | 58.4 | 62.2 | 75.6 | 72.8 | 66.7 |
| Operating Profit | 8.9 | 6.4 | 8.2 | 2.5 | 5.1 | 9.5 | 9.0 | 10.8 | 13.8 | 11.8 |
| OPM % | 11.06% | 8.2% | 9.05% | 3.85% | 6.87% | 13.96% | 12.67% | 12.52% | 15.9% | 15.03% |
| Other Income | 0.3 | 0.1 | 0.5 | 4.6 | 0.6 | 0.3 | 0.6 | 2.3 | 0.4 | 1.3 |
| Interest | 1.2 | 1.2 | 1.3 | 1.4 | 1.8 | 2.5 | 2.0 | 2.6 | 2.2 | 1.9 |
| Depreciation | 2.0 | 2.0 | 2.0 | 2.1 | 2.5 | 2.6 | 2.5 | 2.6 | 2.5 | 2.6 |
| Profit before tax | 6.0 | 3.3 | 5.4 | 1.3 | 1.4 | 4.8 | 5.1 | 7.9 | 9.5 | 8.6 |
| Tax % | 31.9% | 20% | 26.1% | 32% | 48.5% | 34.7% | 34.6% | 25% | 32.3% | 29.8% |
| Net Profit | 4.1 | 2.6 | 4.0 | 2.5 | 0.7 | 3.1 | 3.3 | 5.9 | 6.5 | 6.0 |
| EPS in Rs | 13.58 | 8.71 | 13.26 | 8.17 | 2.32 | 10.31 | 10.96 | 19.63 | 21.37 | 19.87 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 81.3 | 88.3 | 63.7 | 74.7 | 69.3 | 72.1 | 90.0 | 92.5 | 78.5 | 84.6 |
| Expenses | 73.0 | 78.9 | 61.5 | 72.1 | 61.4 | 62.8 | 78.6 | 76.3 | 69.9 | 71.9 |
| Operating Profit | 8.3 | 9.4 | 2.3 | 2.5 | 7.9 | 9.3 | 11.4 | 16.3 | 8.6 | 12.8 |
| OPM % | 10.2% | 10.6% | 3.6% | 3.4% | 11.3% | 12.9% | 12.6% | 17.6% | 10.9% | 15.1% |
| Other Income | 0.1 | 0.5 | 4.8 | 0.6 | 0.3 | 0.6 | 2.4 | 0.4 | 2.0 | 0.1 |
| Interest | 1.7 | 1.7 | 1.8 | 2.2 | 2.8 | 2.3 | 2.8 | 2.4 | 2.1 | 2.1 |
| Depreciation | 2.6 | 2.6 | 2.9 | 3.7 | 3.7 | 3.7 | 3.8 | 3.7 | 3.8 | 3.8 |
| Profit before tax | 4.1 | 5.6 | 0.0 | -2.7 | 1.7 | 3.8 | 7.1 | 10.6 | 4.7 | 6.9 |
| Tax % | 23.8% | 31.3% | 10.7% | -40.4% | 126.6% | 8.2% | 8.8% | 33.3% | 29.8% | 29.8% |
| Net Profit | 3.1 | 3.8 | 2.1 | -3.8 | -0.4 | 4.1 | 6.5 | 7.1 | 3.3 | 4.9 |
| EPS in Rs | 10 | 13 | 5 | -5 | -2 | 14 | 19 | 23 | 15 | 18 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -3% |
| 3 Years: | 5% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -7% |
| 3 Years: | -4% |
| TTM: | 183% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 36% |
| 3 Years: | 16% |
| 1 Year: | 98% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -4% |
| 3 Years: | 5% |
| TTM: | 24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -19% |
| 3 Years: | -22% |
| TTM: | 660% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 36% |
| 3 Years: | 16% |
| 1 Year: | 98% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|